Maryland 2022 Regular Session

Maryland House Bill HB1219

Introduced
2/11/22  
Refer
2/11/22  
Report Pass
3/18/22  
Engrossed
3/21/22  
Refer
3/21/22  
Report Pass
4/4/22  
Enrolled
4/8/22  
Chaptered
5/16/22  

Caption

Pharmacists - Status as Health Care Providers and Study on Reimbursement

Impact

The enactment of HB 1219 is expected to significantly affect state laws regarding health care delivery by expanding the role of pharmacists. With pharmacists recognized as health care providers, they can now be compensated for services that align with their professional scope, which may lead to increased access to health care services for the public. This could also alleviate some burdens on physicians, as pharmacists may handle more preventive or routine care.

Summary

House Bill 1219 aims to formally recognize pharmacists as health care providers in Maryland. This bill alters certain definitions within the law, making pharmacists included in provisions relating to health care malpractice claims, the destruction of medical records, and HIV testing. Furthermore, it mandates that health insurance programs, including the Maryland Medical Assistance Program and the Maryland Children’s Health Program, must provide coverage for services offered by pharmacists, provided these services fall within their scope of practice and are also covered for other healthcare practitioners.

Sentiment

The sentiment around HB 1219 appears largely positive among health care providers and stakeholders that support expanding the capabilities of pharmacists within the healthcare system. Advocates argue that this can enhance patient care and accessibility. However, there may be some concerns from certain healthcare providers fearing that the expansion of pharmacists' responsibilities could blur the lines of professional roles or lead to a potential dilution of care standards.

Contention

Notable points of contention include discussions regarding the adequacy of training pharmacists receive to take on expanded roles typically held by other healthcare providers. Some concerns were raised about the implications of reimbursement policies, particularly how insurance companies would integrate this change into their coverage plans. The establishment of a workgroup by the Maryland Insurance Commissioner to identify reimbursement options highlights both support and apprehensiveness regarding the practical implementation of these provisions.

Companion Bills

No companion bills found.

Similar Bills

MD HB693

State Board of Pharmacy - Board Membership, Delegated Pharmacy Acts, and Sunset Extension

MD HB171

State Board of Pharmacy - Membership - Veterinary Pharmacist

MD SB647

State Board of Pharmacy - Board Membership, Delegated Pharmacy Acts, and Sunset Extension

MD SB661

Pharmacists - Status as Health Care Providers and Study on Reimbursement

MD HB229

Pharmacists - Administration of Injectable Medications for Treatment of Sexually Transmitted Infections

MD SB19

Pharmacists - Administration of Injectable Medications for Treatment of Sexually Transmitted Infections

MD HB1278

Pharmacists - Status as Health Care Providers and Reimbursement

MD HB1151

Health Insurance - Reimbursement for Services Rendered by a Pharmacist